Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection.

Jacobsen T, Sifontis N.

Am J Health Syst Pharm. 2010 Sep 1;67(17):1417-25. doi: 10.2146/ajhp090424. Review.

PMID:
20720240
2.
3.
4.

[Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus infection in transplanted patients].

Torre-Cisneros J, Fortún J, Aguado JM, de la Cámara R, Cisneros JM, Gavaldá J, Gurguí M, Lumbreras C, Martín C, Martín-Dávila P, Montejo M, Moreno A, Muñoz P, Pahissa A, Pérez JL, Rovira M, Bernardos A, Gil-Vernet S, Quijano Y, Rábago G, Román A, Varó E.

Enferm Infecc Microbiol Clin. 2005 Aug-Sep;23(7):424-37. Review. Spanish.

PMID:
16159543
5.

Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.

Steininger C.

Clin Microbiol Infect. 2007 Oct;13(10):953-63. Review.

6.

Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients.

de Maar EF, Verschuuren EA, Harmsen MC, The TH, van Son WJ.

Transpl Infect Dis. 2003 Sep;5(3):112-20. Review.

PMID:
14617298
7.

Prevention and treatment of cytomegalovirus infection in organ transplant recipients.

Kusne S, Shapiro R, Fung J.

Transpl Infect Dis. 1999 Sep;1(3):187-203. Review.

PMID:
11428989
8.

[Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].

Torre-Cisneros J, Caston-Osorio JJ, Martín C, Rivero A, Doblas A, Rojas R, Gómez P, Martínez F, Torres A.

Enferm Infecc Microbiol Clin. 2010 Jan;28(1):6-12. doi: 10.1016/j.eimc.2009.01.010. Epub 2009 May 1. Spanish.

PMID:
19409666
9.

Current and new cytomegalovirus antivirals and novel animal model strategies.

McGregor A.

Inflamm Allergy Drug Targets. 2010 Sep;9(4):286-99. Review.

PMID:
20860547
10.

High-dose oral ganciclovir for management of CMV-symptomatic infection in a child with acute lymphoblastic leukemia.

Castagnola E, Cristina E, Dufour C.

Med Pediatr Oncol. 2002 Apr;38(4):295-6. No abstract available.

PMID:
11920805
11.

Cytomegalovirus in hematopoietic stem cell transplant recipients.

Ljungman P, Hakki M, Boeckh M.

Infect Dis Clin North Am. 2010 Jun;24(2):319-37. doi: 10.1016/j.idc.2010.01.008. Review.

PMID:
20466273
12.

Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients.

Razonable RR.

Am J Health Syst Pharm. 2005 Apr 15;62(8 Suppl 1):S7-13.

PMID:
15821266
13.

Optimal prevention of late-onset cytomegalovirus (CMV) disease and other sequelae of CMV infection in organ transplant recipients.

Singh N.

Clin Infect Dis. 2008 Jul 15;47(2):296-7; author reply 297. doi: 10.1086/589577. No abstract available.

PMID:
18564941
14.

Cytomegalovirus antiviral drug resistance: future prospects for prevention, detection and management.

Hanson KE, Swaminathan S.

Future Microbiol. 2015;10(10):1545-8. doi: 10.2217/fmb.15.82. Epub 2015 Oct 6. No abstract available.

15.

Management of viral infections in solid organ transplant recipients.

Razonable RR.

Expert Rev Anti Infect Ther. 2011 Jun;9(6):685-700. doi: 10.1586/eri.11.43. Review.

PMID:
21692673
16.

Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.

Choi SM, Lee DG, Choi JH, Yoo JH, Kim YJ, Park SH, Park SN, Min CK, Lee S, Kim HJ, Kim DW, Lee JW, Min WS, Shin WS, Kim CC.

Int J Hematol. 2005 Jan;81(1):69-74.

PMID:
15717693
17.

Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.

Hebart H, Brugger W, Grigoleit U, Gscheidle B, Loeffler J, Schäfer H, Kanz L, Einsele H, Sinzger C.

Blood. 2001 Apr 1;97(7):2183-5. No abstract available.

18.

[Infectious diseases in hematopoietic stem cell transplantation recipients].

Mori S.

Rinsho Ketsueki. 2014 Feb;55(2):177-83. Review. Japanese. No abstract available.

PMID:
24598184
19.

Cytomegalovirus treatment options in immunocompromised patients.

Khare MD, Sharland M.

Expert Opin Pharmacother. 2001 Aug;2(8):1247-57. Review.

PMID:
11584992
20.

Combination antiviral strategies in managing cytomegalovirus infection.

Martin M.

Transplant Proc. 1994 Oct;26(5 Suppl 1):28-30. Review. No abstract available.

PMID:
7940973

Supplemental Content

Support Center